胶质瘤
生存素
癌症研究
癌症干细胞
干细胞
紫杉醇
癌细胞
细胞凋亡
化学
生物
癌症
细胞生物学
生物化学
遗传学
作者
Xiyang Sun,Ying Chen,Huijun Zhao,Guanglei Qiao,Meiyang Liu,Chunlei Zhang,Daxiang Cui,Lijun Ma
出处
期刊:Drug Delivery
[Taylor & Francis]
日期:2018-01-01
卷期号:25 (1): 1718-1727
被引量:90
标识
DOI:10.1080/10717544.2018.1494225
摘要
Development of safe, efficient nanocomplex for targeted imaging and therapy of cancer stem cells in brain glioma has become a great challenge. Herein, a low-density lipoprotein receptor-related protein and a RNA aptamer bound CD133 were used as dual-targeting ligands to prepare dual-modified cationic liposomes (DP-CLPs) loaded with survivin siRNA and paclitaxel (DP-CLPs-PTX-siRNA) for actively targeting imaging and treating CD133+ glioma stem cells after passing through the blood-brain barrier. After being administrated with DP-CLPs-PTX-siRNA nanocomplex, DP-CLPs showed a persistent target ability to bind glioma cells and brain microvascular endothelial cells (BCECs) and to deliver drugs (PTX/siRNA) to CD133+ glioma stem cells. Prepared DP-CLPs-PTX-siRNA nanocomplex showed very low cytotoxicity to BCECs, but induced selectively apoptosis of CD133+ glioma stem cells, and improved CD133+ glioma stem cells' differentiation into non-stem-cell lineages, also markedly inhibited tumorigenesis, induced CD133+ glioma cell apoptosis in intracranial glioma tumor-bearing nude mice and improved survival rates. In conclusion, prepared DP-CLPs-PTX-siRNA nanocomplex selectively induced CD133+ glioma stem cell apoptosis in vitro and in vivo exhibits great potential for targeted imaging and therapy of brain glioma stem cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI